145 related articles for article (PubMed ID: 9649559)
21. PICOT inhibits cardiac hypertrophy and enhances ventricular function and cardiomyocyte contractility.
Jeong D; Cha H; Kim E; Kang M; Yang DK; Kim JM; Yoon PO; Oh JG; Bernecker OY; Sakata S; Le TT; Cui L; Lee YH; Kim DH; Woo SH; Liao R; Hajjar RJ; Park WJ
Circ Res; 2006 Aug; 99(3):307-14. PubMed ID: 16809552
[TBL] [Abstract][Full Text] [Related]
22. Phospholamban phosphorylation sites enhance the recovery of intracellular Ca2+ after perfusion arrest in isolated, perfused mouse heart.
Valverde CA; Mundiña-Weilenmann C; Reyes M; Kranias EG; Escobar AL; Mattiazzi A
Cardiovasc Res; 2006 May; 70(2):335-45. PubMed ID: 16516179
[TBL] [Abstract][Full Text] [Related]
23. Inhibition of PKC phosphorylation of cTnI improves cardiac performance in vivo.
Roman BB; Goldspink PH; Spaite E; Urboniene D; McKinney R; Geenen DL; Solaro RJ; Buttrick PM
Am J Physiol Heart Circ Physiol; 2004 Jun; 286(6):H2089-95. PubMed ID: 14726296
[TBL] [Abstract][Full Text] [Related]
24. Apelin and APJ orchestrate complex tissue-specific control of cardiomyocyte hypertrophy and contractility in the hypertrophy-heart failure transition.
Parikh VN; Liu J; Shang C; Woods C; Chang AC; Zhao M; Charo DN; Grunwald Z; Huang Y; Seo K; Tsao PS; Bernstein D; Ruiz-Lozano P; Quertermous T; Ashley EA
Am J Physiol Heart Circ Physiol; 2018 Aug; 315(2):H348-H356. PubMed ID: 29775410
[TBL] [Abstract][Full Text] [Related]
25. PKC-alpha regulates cardiac contractility and propensity toward heart failure.
Braz JC; Gregory K; Pathak A; Zhao W; Sahin B; Klevitsky R; Kimball TF; Lorenz JN; Nairn AC; Liggett SB; Bodi I; Wang S; Schwartz A; Lakatta EG; DePaoli-Roach AA; Robbins J; Hewett TE; Bibb JA; Westfall MV; Kranias EG; Molkentin JD
Nat Med; 2004 Mar; 10(3):248-54. PubMed ID: 14966518
[TBL] [Abstract][Full Text] [Related]
26. The deltaC isoform of CaMKII is activated in cardiac hypertrophy and induces dilated cardiomyopathy and heart failure.
Zhang T; Maier LS; Dalton ND; Miyamoto S; Ross J; Bers DM; Brown JH
Circ Res; 2003 May; 92(8):912-9. PubMed ID: 12676814
[TBL] [Abstract][Full Text] [Related]
27. Functional effects of protein kinase C-mediated myofilament phosphorylation in human myocardium.
van der Velden J; Narolska NA; Lamberts RR; Boontje NM; Borbély A; Zaremba R; Bronzwaer JG; Papp Z; Jaquet K; Paulus WJ; Stienen GJ
Cardiovasc Res; 2006 Mar; 69(4):876-87. PubMed ID: 16376870
[TBL] [Abstract][Full Text] [Related]
28. Ischemic protection and myofibrillar cardiomyopathy: dose-dependent effects of in vivo deltaPKC inhibition.
Hahn HS; Yussman MG; Toyokawa T; Marreez Y; Barrett TJ; Hilty KC; Osinska H; Robbins J; Dorn GW
Circ Res; 2002 Oct; 91(8):741-8. PubMed ID: 12386152
[TBL] [Abstract][Full Text] [Related]
29. Reduced cardiac CapZ protein protects hearts against acute ischemia-reperfusion injury and enhances preconditioning.
Yang FH; Pyle WG
J Mol Cell Cardiol; 2012 Mar; 52(3):761-72. PubMed ID: 22155006
[TBL] [Abstract][Full Text] [Related]
30. Alterations in myofilament function contribute to left ventricular dysfunction in pigs early after myocardial infarction.
van der Velden J; Merkus D; Klarenbeek BR; James AT; Boontje NM; Dekkers DH; Stienen GJ; Lamers JM; Duncker DJ
Circ Res; 2004 Nov; 95(11):e85-95. PubMed ID: 15528471
[TBL] [Abstract][Full Text] [Related]
31. Extracellular Histone-Induced Protein Kinase C Alpha Activation and Troponin Phosphorylation Is a Potential Mechanism of Cardiac Contractility Depression in Sepsis.
Abrams ST; Alhamdi Y; Zi M; Guo F; Du M; Wang G; Cartwright EJ; Toh CH
Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36834636
[TBL] [Abstract][Full Text] [Related]
32. Enhanced N-terminal degradation of troponin I blunts cardiac function responsiveness to isoproterenol in 4-week tail-suspended rats.
Zhang L; Song Z; Chang H; Wang YY; Yu ZB
Mol Med Rep; 2013 Jan; 7(1):271-9. PubMed ID: 23042367
[TBL] [Abstract][Full Text] [Related]
33. Cardiac-specific overexpression of a high Ca2+ affinity mutant of SERCA2a attenuates in vivo pressure overload cardiac hypertrophy.
Nakayama H; Otsu K; Yamaguchi O; Nishida K; Date MO; Hongo K; Kusakari Y; Toyofuku T; Hikoso S; Kashiwase K; Takeda T; Matsumura Y; Kurihara S; Hori M; Tada M
FASEB J; 2003 Jan; 17(1):61-3. PubMed ID: 12424227
[TBL] [Abstract][Full Text] [Related]
34. Transgenic mouse model of stunned myocardium.
Murphy AM; Kögler H; Georgakopoulos D; McDonough JL; Kass DA; Van Eyk JE; Marbán E
Science; 2000 Jan; 287(5452):488-91. PubMed ID: 10642551
[TBL] [Abstract][Full Text] [Related]
35. Enhanced myofilament responsiveness upon β-adrenergic stimulation in post-infarct remodeled myocardium.
Boontje NM; Merkus D; Zaremba R; Versteilen A; de Waard MC; Mearini G; de Beer VJ; Carrier L; Walker LA; Niessen HW; Dobrev D; Stienen GJ; Duncker DJ; van der Velden J
J Mol Cell Cardiol; 2011 Mar; 50(3):487-99. PubMed ID: 21156182
[TBL] [Abstract][Full Text] [Related]
36. Ischemic dysfunction in transgenic mice expressing troponin I lacking protein kinase C phosphorylation sites.
MacGowan GA; Du C; Cowan DB; Stamm C; McGowan FX; Solaro RJ; Koretsky AP; Del Nido PJ
Am J Physiol Heart Circ Physiol; 2001 Feb; 280(2):H835-43. PubMed ID: 11158984
[TBL] [Abstract][Full Text] [Related]
37. In vivo alpha-adrenergic responses and troponin I phosphorylation: anesthesia interactions.
MacGowan GA; Rager J; Shroff SG; Mathier MA
J Appl Physiol (1985); 2005 Apr; 98(4):1163-70. PubMed ID: 15579573
[TBL] [Abstract][Full Text] [Related]
38. Differential regulation of cardiac actomyosin S-1 MgATPase by protein kinase C isozyme-specific phosphorylation of specific sites in cardiac troponin I and its phosphorylation site mutants.
Noland TA; Raynor RL; Jideama NM; Guo X; Kazanietz MG; Blumberg PM; Solaro RJ; Kuo JF
Biochemistry; 1996 Nov; 35(47):14923-31. PubMed ID: 8942657
[TBL] [Abstract][Full Text] [Related]
39. Prevention of myofilament dysfunction by beta-blocker therapy in postinfarct remodeling.
Duncker DJ; Boontje NM; Merkus D; Versteilen A; Krysiak J; Mearini G; El-Armouche A; de Beer VJ; Lamers JM; Carrier L; Walker LA; Linke WA; Stienen GJ; van der Velden J
Circ Heart Fail; 2009 May; 2(3):233-42. PubMed ID: 19808345
[TBL] [Abstract][Full Text] [Related]
40. Single histidine-substituted cardiac troponin I confers protection from age-related systolic and diastolic dysfunction.
Palpant NJ; Day SM; Herron TJ; Converso KL; Metzger JM
Cardiovasc Res; 2008 Nov; 80(2):209-18. PubMed ID: 18635554
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
